Axsome Therapeutics (AXSM) Amortization of Deferred Charges (2015 - 2017)
Axsome Therapeutics' (AXSM) quarterly Amortization of Deferred Charges came in at $85628.0 in Q4 2017, down 2.78% quarter-over-quarter from $88074.0 in Q3 2017.
Axsome Therapeutics (AXSM) Amortization of Deferred Charges (2015 - 2017) Analysis & Trends
Axsome Therapeutics has disclosed Amortization of Deferred Charges across 2 years of filings, most recently posting $85628.0 for Q4 2017.
- Amortization of Deferred Charges for Q4 2017 came in at $85628.0, changed N/A year-over-year; the trailing twelve-month figure through Dec 2017 was $346978.0 (changed N/A YoY), and the FY2017 annual result was $346978.0, up 597.01% from the prior year.
- Amortization of Deferred Charges came in at $85628.0 for Q4 2017 at Axsome Therapeutics, down from $88074.0 in the prior quarter.
- In the past five years, Amortization of Deferred Charges ranged from a high of $88074.0 in Q3 2017 to a low of $1806.0 in Q1 2015.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Axsome Therapeutics | 12.84 Bn | 12.54 Bn | 176.48 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2017 | 85,628.00 |
| Dec 31, 2017 | 85,628.00 |
| Sep 30, 2017 | 88,074.00 |
| Sep 30, 2017 | 88,074.00 |
| Jun 30, 2017 | 87,117.00 |
| Jun 30, 2017 | 87,117.00 |
| Mar 31, 2017 | 86,159.00 |
| Mar 31, 2017 | 86,159.00 |
| Sep 30, 2015 | 2,235.00 |
| Sep 30, 2015 | 2,235.00 |
| Jun 30, 2015 | 3,716.00 |
| Jun 30, 2015 | 3,716.00 |
| Mar 31, 2015 | 1,806.00 |
| Mar 31, 2015 | 1,806.00 |